(0.15%) 5 162.50 points
(0.13%) 38 881 points
(0.12%) 18 023 points
(0.82%) $78.75
(0.61%) $2.16
(0.58%) $2 322.10
(2.42%) $27.34
(0.24%) $967.65
(0.01%) $0.929
(-0.31%) $10.84
(-0.17%) $0.796
(0.12%) $91.56
@ $46.00
发出时间: 15 Feb 2024 @ 04:28
回报率: -2.83%
上一信号: Feb 9 - 23:32
上一信号:
回报率: 2.68 %
Live Chart Being Loaded With Signals
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally...
Stats | |
---|---|
今日成交量 | 62 939.00 |
平均成交量 | 53 393.00 |
市值 | 566.09M |
EPS | $0.390 ( 2024-05-02 ) |
下一个收益日期 | ( $0.330 ) 2024-06-14 |
Last Dividend | $1.050 ( 2023-02-10 ) |
Next Dividend | $0 ( N/A ) |
P/E | 33.11 |
ATR14 | $0.0670 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-26 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-27 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-21 | Susi Roger E. | Sell | 300 000 | Common Stock |
2023-12-18 | Susi Roger E. | Sell | 5 000 | Common Stock |
2023-12-19 | Susi Roger E. | Sell | 5 000 | Common Stock |
INSIDER POWER |
---|
-83.04 |
Last 100 transactions |
Buy: 59 851 | Sell: 665 743 |
音量 相关性
IRadimed Corp 相关性 - 货币/商品
IRadimed Corp 财务报表
Annual | 2023 |
营收: | $65.56M |
毛利润: | $50.16M (76.50 %) |
EPS: | $1.360 |
FY | 2023 |
营收: | $65.56M |
毛利润: | $50.16M (76.50 %) |
EPS: | $1.360 |
FY | 2022 |
营收: | $53.30M |
毛利润: | $41.28M (77.45 %) |
EPS: | $1.020 |
FY | 2021 |
营收: | $41.81M |
毛利润: | $32.05M (76.65 %) |
EPS: | $0.760 |
Financial Reports:
No articles found.
IRadimed Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.050 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.000 | 2022-02-16 |
Last Dividend | $1.050 | 2023-02-10 |
Next Dividend | $0 | N/A |
Payout Date | 2023-02-21 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $2.05 | -- |
Avg. Dividend % Per Year | 1.58% | -- |
Score | 3.73 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.27 | |
Div. Directional Score | 8.58 | -- |
Year | Amount | Yield |
---|---|---|
2022 | $1.000 | 2.09% |
2023 | $1.050 | 3.69% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Royal | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.265 | 1.500 | 4.70 | 7.06 | [0 - 0.5] |
returnOnAssetsTTM | 0.204 | 1.200 | 3.21 | 3.85 | [0 - 0.3] |
returnOnEquityTTM | 0.246 | 1.500 | 8.37 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.44 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 7.64 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 5.92 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0220 | -1.500 | 9.63 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 60.68 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.003 | 2.00 | 9.67 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.851 | 2.00 | 9.57 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0255 | -1.500 | 9.90 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.766 | 1.000 | 0.572 | 0.572 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.307 | 1.000 | 5.86 | 5.86 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 6.55 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.769 | 0.800 | 8.21 | 6.57 | [0.5 - 2] |
Total Score | 11.89 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 31.58 | 1.000 | 6.91 | 0 | [1 - 100] |
returnOnEquityTTM | 0.246 | 2.50 | 8.96 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.851 | 2.00 | 9.72 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.409 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.003 | 2.00 | 9.67 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.302 | 1.500 | -1.323 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.188 | 1.000 | 7.81 | 0 | [0.1 - 0.5] |
Total Score | 5.27 |
IRadimed Corp
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。